Success Story: NIW Approved Without RFE! Our Team Assisted an Iranian Researcher in Securing Success
Client’s Testimonial:
“I am completely satisfied with the way you work.”
On October 22nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Clinical Biochemistry (Approval Notice).
General Field: Clinical Biochemistry
Position at the Time of Case Filing: Researcher
Country of Origin: Iran
Country of Residence at the Time of Filing: Iran
Approval Notice Date: October 22nd, 2025
Processing Time: 22 months, 16 days
Case Summary:
Drawing on our extensive experience and proven history of successful NIW filings, our team at North America Immigration Law Group recently secured National Interest Waiver approval for a clinical biochemistry researcher focused on combating some of the most prevalent chronic diseases in the United States.
The client holds a Ph.D. in Chemical Pathology and is a recognized expert in clinical biochemistry. The proposed endeavor centers on advancing mechanistic understanding and treatment strategies for diabetes, cardiovascular disease, and oral cancer—conditions with significant health and economic burdens nationwide. By strategically presenting the national value of this research area and the client’s demonstrated record of success, we secured approval of the I-140 NIW petition.
Research with Substantial Merit and National Importance
The petition emphasized the client’s vital research contributions toward improving clinical care for chronic and life-threatening conditions. The work includes uncovering biochemical drivers of metabolic disorders and cardiovascular complications, as well as identifying biomarkers that support earlier diagnosis and improved patient outcomes. These advancements support ongoing efforts to reduce long-term healthcare costs and improve the quality of life for millions of Americans.
To further validate the client’s prominence and continued role in advancing scientific progress, four experts in the field submitted strong recommendation letters.
Evidence of Established Expertise and Scientific Influence
Our team demonstrated that the client is well-positioned to continue advancing this critical area of healthcare innovation by presenting:
- 16 peer-reviewed journal articles, including first-authored research on nationally significant clinical topics
- 369 citations from independent researchers who have relied on these findings to advance their own work
- Multiple ongoing research initiatives are directly aligned with U.S. public health priorities
This objective record made clear that the client’s scientific contributions are both original and widely recognized.
The Result
USCIS approved the National Interest Waiver petition, confirming that the client’s research achievements and future plans meet the rigorous Dhanasar criteria. This approval underscores that innovative work in clinical biochemistry—when supported with authoritative documentation and strategic positioning—clearly fulfills national interest requirements.
We are honored to support this highly qualified researcher and look forward to the continued positive impact this work will have on the future of diabetes, cardiovascular disease, and cancer research in the United States.